Gemini Therapeutics, Inc. /DE·4

Jan 5, 4:08 PM ET

Meyenburg Jason Patrick 4

4 · Gemini Therapeutics, Inc. /DE · Filed Jan 5, 2022

Insider Transaction Report

Form 4
Period: 2022-01-03
Meyenburg Jason Patrick
DirectorPresident & CEO
Transactions
  • Award

    Restricted Stock Units

    2022-01-03+123,600123,600 total
    Common Stock (123,600 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock.
  • [F2]These Restricted Stock Units shall vest in accordance with certain performance based metrics.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT